Highly Sucessful Spinoff Furiex Pharmaceuticals To Be Acquired By Forest Labs

Another buyout of a successful spin hit the newswire earlier this week when Forest Laboratories (FRX) announced that it would acquire Furiex Pharmaceuticals (FURX) for $95 per share in cash. Furiex was spun out of PPD (which has since been acquired) back in 2010 and had been on a tear after dropping out of the gate. Most recently, the… Read More »